BIT 4.76% 2.2¢ biotron limited

Ann: Shareholder Update , page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 99 Posts.
    lightbulb Created with Sketch. 5
    No guesses? Answer March 2009. Yep, over 3 years ago discussions had been ongoing "for some time". Face the facts guys, the big pharmas don't like it



    " following a successful completion of this human trial, the Company will focus its efforts on completing a commercial deal with a pharmaceutical company to continue the development of BIT225 to a marketable drug. Discussions with a number of pharmaceutical companies have been ongoing for some time and BIT225 is well known in the drug development industry"
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.